Floatz logo

Tetanus Toxoid

Relapsing Multiple Sclerosis

CelgenevaccinePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
81/ 100

Competitive context

19 Active assets in the Relapsing Multiple Sclerosis cohort.

Asset / SponsorPhaseRating
Peginterferon Beta-1A
Biogen
Phase 4BBB
Humax-Cd20
University Hospital, Montpellier
Phase 4BBB
Teriflunomide
University Hospital, Montpellier
Phase 4BBB
Quadrivalent Inactivated Influenza Vaccine
Novartis Pharmaceuticals
Phase 4BB
Tolebrutinib
Sanofi
Phase 3BB

View all 30 →

Same molecule, other indications

Tetanus Toxoid is also rated in:

PertussisDormant
BB
Indicative ·
65 / 100
View asset →
multiple sclerosisDormant
B
Indicative ·
63 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →